[1]
F. Yousefi, “The Effects of Selective Serotonin Reuptake Inhibitors on Neurological and Depressive Symptoms in Multiple Sclerosis: A Systematic Review and Meta‐analysis of Randomized Controlled Trials: SSRIs in Multiple Sclerosis: Meta-analysis: SSRIs in Multiple Sclerosis: Meta-analysis”, Galen Med J, vol. 12, p. e3153, Dec. 2023.